{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:11Z","timestamp":1791328991792,"version":"4.3.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.actatropica.2017.04.029","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T18:50:56Z","timestamp":1493405456000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"special_numbering":"C","title":["Application of nanotechnology in treatment of leishmaniasis: A Review"],"prefix":"10.1016","volume":"172","author":[{"given":"Maryam","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Oryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Hatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2017.04.029_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.exppara.2016.04.008","article-title":"A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles\u2014Nigella sativa oil combinations","volume":"166","author":"Abamor","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/fmb.11.78","article-title":"Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug resistant bacteria and leishmania parasites","volume":"6","author":"Allahverdiyev","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exppara.2013.06.001","article-title":"Investigation of antileishmanial activities of Tio2@ Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro","volume":"135","author":"Allahverdiyev","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0001-706X(00)00064-4","article-title":"Characterization of Leishmania isolated in Iran: 1. Serotyping with specific monoclonal antibodies","volume":"75","author":"Ardehali","year":"2000","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0035","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1007\/s00436-015-4707-5","article-title":"Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major","volume":"114","author":"Bahrami","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jtemb.2012.11.002","article-title":"Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies","volume":"27","author":"Beheshti","year":"2013","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ch\u00e1vez-Fumagalli","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2212current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0060","first-page":"835","article-title":"Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB\/c mice","volume":"6","author":"Danesh-Bahreini","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/pat.1710","article-title":"Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation","volume":"22","author":"Das","year":"2010","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0070","first-page":"0141788","article-title":"Miltefosine lipid nanocapsules for single dose oral treatment of Schistosomiasis Mansoni: a preclinical study","author":"Eissa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3155-3-6","article-title":"Interaction of silver nanoparticles with HIV-1","volume":"3","author":"Elechiguerra","year":"2005","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/1061186021000060738","article-title":"In vitro antileishmanial activity of amphotericin B loaded inpoly (epsilon-caprolactone) nanospheres","volume":"10","author":"Espuelas","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0085","doi-asserted-by":"crossref","first-page":"e2871","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and antimonial drug susceptibility of Leishmania\/Viannia species and populations in regions of high transmission in Colombia","volume":"8","author":"Fernandez","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0090","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.jinorgbio.2008.05.010","article-title":"Metal compounds for the treatment of parasitic diseases","volume":"102","author":"Fricker","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1051\/parasite\/2014016","article-title":"Antileishmanial activity of a mixture of Tridax procumbensand Allium sativumin mice","volume":"21","author":"Gamboa-Leon","year":"2014","journal-title":"Parasite"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00034983.1992.11812629","article-title":"Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine loaded nanoparticles against intracellular Leishmania donovani","volume":"86","author":"Gaspar","year":"1992","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkp140","article-title":"Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation","volume":"64","author":"Gershkovich","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0120","first-page":"90","article-title":"Evaluating the efficacy of topical silver nitrate and intramuscular antimonial drugs in the treatment of cutaneous leishmaniasis in sokoto, Nigeria","volume":"13","author":"Igbineweka","year":"2012","journal-title":"Afr. J. Clin. Exp. Microbiol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.exppara.2013.07.018","article-title":"Identification of antimony resistance markers in Leishmaniat ropica field isolates through a cDNA-AFLP approach","volume":"135","author":"Kazemi-Rad","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF01644038","article-title":"Liposomes and nanoparticles as vehicles for antibiotics","volume":"19","author":"Kreuter","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0145","first-page":"85","article-title":"PLGA-PEG Encapsulated sitamaquine nanoparticles drug delivery system against Leishmania donovani","volume":"3","author":"Kumara","year":"2014","journal-title":"JSIR"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0150","first-page":"69","article-title":"Review of the current treatments for leishmaniases","volume":"3","author":"Lindoso","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0155","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1093\/nar\/gkl541","article-title":"Selenium metabolism in Trypanosoma: characterization of selenoproteomes and identification of a Kinetoplastid-specific selenoprotein","volume":"34","author":"Lobanov","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0160","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/jm981074c","article-title":"Cytotoxicity of (2,20:6,200-terpyridine) platinum (II) complexes to Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei","volume":"42","author":"Lowe","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0165","first-page":"452","article-title":"In vitro study of Leishmanicidal activity of biogenic selenium nanoparticles against iranian isolate of sensitive and glucantime-resistant Leishmania tropica","volume":"9","author":"Mahmoudvand","year":"2014","journal-title":"Iran J. Parasitol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/2008-2231-21-58","article-title":"Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel","volume":"21","author":"Manoochehri","year":"2013","journal-title":"Daru"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0180","first-page":"3","article-title":"Nano suspensions asparticulate drug formulations in therapy: rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0185","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances inleishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0190","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.drudis.2010.10.005","article-title":"Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives","volume":"15","author":"Navarro","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0195","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apjtm.2016.06.021","article-title":"Worldwide risk factors in leishmaniasis","volume":"9","author":"Oryan","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00580-007-0693-z","article-title":"Histopathologic and electron microscopic characterization of cutaneous leishmaniasis in Tateraindica and Gerbillus spp. infected with Leishmania major","volume":"16","author":"Oryan","year":"2007","journal-title":"Comp. Clin. Pathol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09712119.2008.9706946","article-title":"Morphologic Changes due to Cutaneous Leishmaniosis in BALB\/c Mice Experimentally Infected with Leishmania major","volume":"34","author":"Oryan","year":"2008","journal-title":"J. Appl. Anim. Res."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.meegid.2013.07.021","article-title":"Genetic diversity of Leishmania major strains isolated from different clinical forms of cutaneous leishmaniasis in southern Iran based on minicircle kDNA","volume":"19","author":"Oryan","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0215","first-page":"1","article-title":"Plant-derived compounds in treatment of leishmaniasis","volume":"16","author":"Oryan","year":"2015","journal-title":"Iran J. Vet. Res."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0220","doi-asserted-by":"crossref","first-page":"16248","DOI":"10.1021\/jp063826h","article-title":"Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity","volume":"110","author":"Panacek","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0225","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1166\/jnn.2014.9578","article-title":"Nanotechnology for diagnosis and treatment of infectious diseases","volume":"14","author":"Qasim","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","article-title":"The importance of selenium to human health","volume":"356","author":"Rayman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0235","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/AAC.42.5.1076","article-title":"Characterization of the antimonial antileishmanial agent meglumine antimonate (Glucantime)","volume":"42","author":"Roberts","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0240","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/17425247.5.7.805","article-title":"Drug delivery systems against leishmaniasis? Still an open question","volume":"5","author":"Romero","year":"2008","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0245","first-page":"73","article-title":"Biological targeting and drug delivery in control of Leishmaniasis","volume":"6","author":"Roy","year":"2012","journal-title":"J. Cell Anim. Biol."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0250","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s00436-013-3387-2","article-title":"Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis","volume":"112","author":"Sachdeva","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/02656736.2012.758875","article-title":"Antiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major","volume":"29","author":"Sazgarnia","year":"2013","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2010.03.008","article-title":"Efficacy of artemisinin in experimental visceral leishmaniasis","volume":"36","author":"Sen","year":"2010","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0265","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tmaid.2013.09.001","article-title":"Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study","volume":"12","author":"Shafiei","year":"2014","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1179\/2047773213Y.0000000098","article-title":"Three Leishmania\/L. species\u2014L. infantum, L. major, L. tropica\u2014as causative agents of mucosal leishmaniasis in Iran","volume":"107","author":"Shirian","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5858\/arpa.2013-0098-OA","article-title":"Comparison of conventional, molecular, and immunohistochemical methods in diagnosis of typical and atypical cutaneous leishmaniasis","volume":"138","author":"Shirian","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S0074-02762011000100004","article-title":"Immune and inflammatory responses to Leishmania amazonensis isolated from different clinical forms of human leishmaniasis in CBA mice","volume":"106","author":"Souza","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0285","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1016\/j.biomaterials.2009.07.030","article-title":"The disruption of bacterial membrane integrity through ROS generation induced by nano hybrids of silver and clay","volume":"30","author":"Su","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0295","first-page":"345","article-title":"Visceral leishmaniasis-current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0300","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management","volume":"3","author":"Sundar","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0305","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0310","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.2007.76.579","article-title":"Cross-protection against Leishmania donovani but not L. braziliensis caused by vaccination with L. major soluble promastigote exogenous antigens in BALB\/c mice","volume":"76","author":"Tonui","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0315","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2011.08.016","article-title":"PLGA nanoparticles loaded with the antileishmanial saponin \u03b2-aescin: factor influence study and in vitro efficacy evaluation","volume":"420","author":"Van de Ven","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0320","first-page":"194","article-title":"Formulation and evaluation of oil in water emulsions of piperine in visceral leishmaniasis","volume":"59","author":"Veerareddy","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0325","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/10611860802528833","article-title":"Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres","volume":"17","author":"Veerareddy","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/nano.2006.1.4.417","article-title":"Optimizing efficacy of amphotericin B through nanomodification","volume":"1","author":"Vyas","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2014.06.035","article-title":"A newapproach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies","volume":"432","author":"Want","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0340","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/TCRM.S30139","article-title":"Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)","volume":"8","author":"Wiwanitkit","year":"2012","journal-title":"Ther. Clin. Risk. Manag."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0345","first-page":"22","article-title":"Control of the leishmaniases","volume":"949","author":"World Health Organization","year":"2010","journal-title":"World Health Organ Tech. Rep. Ser."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0350","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0001-706X(01)00085-7","article-title":"Epidemiological study in a new focus of cutaneous leishmaniasis due to L. major in Ardestan town central Iran","volume":"79","author":"Yaghoobi-Ershadi","year":"2001","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2017.04.029_bib0355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2017.04.029_bib0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.exppara.2013.07.008","article-title":"Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL\/6 mice","volume":"135","author":"de Carvalho","year":"2013","journal-title":"Exp. Parasitol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X17300748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X17300748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T07:57:06Z","timestamp":1569139026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X17300748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":72,"alternative-id":["S0001706X17300748"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2017.04.029","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of nanotechnology in treatment of leishmaniasis: A Review","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2017.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}